BeStock  
Stocks › Biotechnology › STOK

Stoke Therapeutics STOK

US equityMarket cap rank #2926Biotechnology
$25.32 −$0.30 (-1.17%)
Pre-market · Oct 6, 4:10 am ET · After hours $25.32 0.00%
Open$25.82
Prev close$25.62
Day range$24.84 – $26.31
Volume928.4K
Market cap$1.63B
P/E (TTM)–
Dividend yield–

STOK Stock News

Headlines matching Stoke Therapeutics or the STOK ticker, most recent first.

  • A Quick Look at Today's Ratings for Stoke Therapeutics(STOK.US), With a Forecast Between $40 to $60Market news · 5 Aug 2026
  • Analysts Are Bullish on These Healthcare Stocks: Stoke Therapeutics (STOK), Fortrea Holdings Inc. (FTRE)TipRanks · 4 Aug 2026
  • Chardan Capital Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $35Market news · 4 Aug 2026
  • J.P. Morgan Upgrades Stoke Therapeutics(STOK.US) to Buy Rating, Raises Target Price to $40Market news · 21 Aug 2026
  • CCORF Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $58Market news · 13 Aug 2026
  • Needham Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $40Market news · 9 Jul 2026
  • Jefferies Initiates Stoke Therapeutics(STOK.US) With Buy Rating, Announces Target Price $44Market news · 14 Jul 2026
  • Analysts Offer Insights on Healthcare Companies: Stoke Therapeutics (STOK), Genelux Corp. (GNLX) and Celldex (CLDX)TipRanks · 9 May 2026
  • A Quick Look at Today's Ratings for Stoke Therapeutics(STOK.US), With a Forecast Between $38 to $60Market news · 9 May 2026
  • TD Cowen Maintains Stoke Therapeutics(STOK.US) With Buy RatingMarket news · 8 May 2026
  • Guggenheim Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $60Market news · 8 May 2026
  • BTIG Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $39Market news · 11 May 2026
  • H.C. Wainwright Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $50Market news · 22 Apr 2026
  • CCORF Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Raises Target Price to $60Market news · 20 Mar 2026
  • Wedbush Maintains Stoke Therapeutics(STOK.US) With Buy Rating, Maintains Target Price $38Market news · 18 Mar 2026

Discussion

No comments yet — be the first to weigh in on STOK.

Leave a comment

Scroll to Top